Get startedLog in
    Picture of Paradigm Biopharmaceuticals logo

    PAR — Paradigm Biopharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeSmall Cap
    All News

    Brief: Paradigm Biopharmaceuticals HY Net Loss Attributable A$49.0 Million

    Picture of Paradigm Biopharmaceuticals logoParadigm Biopharmaceuticals
    28/02/2024 06:08
    Feb 28 (Reuters) - Paradigm Biopharmaceuticals Ltd
 PAR.AX :
    * HY NET LOSS ATTRIBUTABLE A$49.0 MILLION
    * HY  REVENUE FROM CONTINUING ACTIVITIES A$1.3 MILLION

Source text for Eikon:  ID:nASX48gVYS 
Further company coverage:  PAR.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Paradigm Biopharmaceuticals

    See all news